Gleamer Expands AI-Driven Imaging Portfolio with Acquisitions of Pixyl and Caerus Medical
Gleamer, a leading AI-driven medical imaging company, has acquired two pioneering firms—Pixyl, the first to deliver FDA- and CE-cleared neuro MRI applications, and Caerus Medical, a firm that creates innovative lumbar MRI AI solutions. These transactions establish Gleamer as the sole AI company with a full range of solutions for X-ray, Mammography, CT, and MRI.
Growing the AI-Driven Imaging Portfolio
With the acquisition of Pixyl and Caerus Medical, Gleamer now has the largest AI-based imaging portfolio in the market. This allows the company to equip radiologists with cutting edge tools that improve diagnostic accuracy, automate workflows, and speed up patient care. Gleamer's capabilities make it the best option for medical facilities that are loooking for complete AI integration in their imaging workflows.
Christian Allouche, CEO and co-founder of Gleamer, said, "With the addition of Pixyl and Caerus Medical, Gleamer now offers the most extensive proprietary AI-driven imaging portfolio in the industry. This move marks a transformative leap forward, empowering radiologists with cutting edge MRI applications while strengthening our leadership in medical imaging AI."
Pixyl, an award-winning brain innovator in MRI analysis innovation, gained a lot of attention for its product, Pixyl.Neuro. The application allows for early detection of neuroinflammatory and neurodegenerative conditions such as Alzheimer's disease. Increasing reimbursement in the US will ensure that Pixyl grows exponentially into a dominant industry player in radiology powered by AI.
Caerus Medical: Revolutionizing Lumbar Spine MRI
Caerus Medical's AI technology interprets lumbar spine MRI better, with excellent accuracy in the detection of disc herniation, stenosis, and spondylolisthesis. This wide based strategy optimizes workflow efficiency as well as diagnostic accuracy to allow radiologists to deliver faster and more accurate reports.
Following the acquisitions, Gleamer's team increased to more than 100 workers in seven countries, enhancing its MRI research and development capabilities. The integration of Pixyl and Caerus Medical into Gleamer's AI Factory will also boost the development of advanced imaging products for radiology at a faster rate.
